An assessment model for efficacy of autologous CD19 chimeric antigen receptor T-cell therapy and relapse or refractory diffuse large B-cell lymphoma risk.
- Author:
Bin XUE
1
;
Yifan LIU
1
;
Min ZHANG
1
;
Gangfeng XIAO
1
;
Xiu LUO
1
;
Lili ZHOU
1
;
Shiguang YE
1
;
Yan LU
1
;
Wenbin QIAN
2
;
Li WANG
3
;
Ping LI
1
;
Aibin LIANG
1
Author Information
- Publication Type:Journal Article
- From: Chinese Medical Journal 2025;138(1):108-110
- CountryChina
- Language:English
